Stock IdeasStrong Buy StocksStrong Buy Stocks from Top Wall Street AnalystsLatest stocks with a Strong Buy rating from the top performing 25% of analysts tracked by WallStreetZen
| Analyst / Firm | Company | Price | Rating | Price Target | Upside/Downside | Date |
|---|---|---|---|---|---|---|
Teva Pharmaceutical Industries LtdTEVA | $36.36 | Strong Buy | $48.00 | +32.01% | 16 hours ago | |
Analyst RankingTop 11% #579 out of 5504 analysts Average Return+14.07% Win Rate61%63 out of 103 Risk vs RewardPoor Good Analyst ColorUBS's Ashwani Verma raised their price target on Teva Pharmaceutical Industries (NYSE: TEVA) by 14.3% from $42 to $48 on 2026/09/04. The analyst maintained their Strong Buy rating on the stock. Verma attributed their price target raise to Teva Pharmaceutical Industries' Phase 2 success in celiac, calling the data an "important milestone." The analyst reminded readers that Teva Pharmaceutical Industries has historically been a generics company, and argued that the "impressive" results are a key reason the stock warrants a significant premium against its current multiple. Looking ahead, Verma added that a "catalyst-rich" 2027 is visible for the company. | ||||||
Tesla IncTSLA | $800.00 | Strong Buy | $850.00 | +6.25% | a day ago | |
Upgrade to Premium to View MoreStrong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts Already have access to Premium? Sign In | ||||||
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.